強制收回風險 Sample Clauses

強制收回風險. 投資者買賣牛熊證,須留意牛熊證可以即日「取消」或強制收回的特色。若牛熊證的相關資產值等同上市文件所述的強制收回價/水平,牛熊證即停止買賣。屆時,投資者只能收回已停止買賣的牛熊證由產品發行商按上市文件所述計算出來的剩餘價值(注意:剩餘價值可以是零)。
AutoNDA by SimpleDocs
強制收回風險. 投資者買賣牛熊證,須留意牛熊證可以即日「取消」或強制收回的特。若牛熊證的相關資產值等同上市文件所述的強制收回價/水平,牛熊證即 value equals the mandatory call price/level as stated in the listing documents. Investors will only be entitled to the residual value of the terminated CBBC as calculated by the product issuer in accordance with the listing documents. Investors should also note that the residual value can be zero.
強制收回風險. Mandatory call risk 投資者須留意牛熊證可能即日「取消」或強制收回的風險。若牛熊證的相關資產值等同上市文件所述的強制收回價,該 牛熊證即會停止買賣。屆時,投資者只能收回已停止買賣的牛熊證由產品發行商按照上市文件所述計算出來的剩餘價值,而剩餘價值可能是零。當牛熊證被收回後,即使相關資產價格反彈,該隻牛熊證亦不會再次復牌在市場上買賣,故投資 者不會因價格反彈而獲利。一般來說,收回價與相關資產現價的相差愈大,牛熊證被收回的機會愈低,因為相關資產的 價格需要較大的變動才會觸及收回價。但同一時間,收回價與現價的相差愈大,槓桿作用便愈小。 Investors trading CBBCs should be aware of their intraday “knockout” or mandatory call feature. A CBBC will cease trading when the underlying asset value equals the mandatory Call Price as stated in the listing documents. Investors will only be entitled to the residual value of the terminated CBBCs as calculated by the product issuer in accordance with the listing documents, and the residual value can be zero. Once the CBBC is called, even though the underlying asset may bounce back in the right direction, the CBBC which has been called will not be revived and investors will not be able to profit from the bounce back. In general, the larger the buffer between the Call Price and the Spot Price of the underlying asset, the lower the probability of the CBBC being called since the underlying asset of that CBBC would have to experience a larger movement in the price before the CBBC will be called. However, at the same time, the larger the buffer, the lower the leverage effect will be.
強制收回風險. 投資者買賣牛熊證,須留意牛熊證可以即日「取消」或強制收回的特色。若牛熊證的相關資產值等同上市文件所述的強制收回價/水平,牛熊證即停止買賣。屆時,投資者只能收回已停止買賣的牛熊證由產品發行商按上市文件所述計算出來的剩餘價值 (注意:剩餘價值可以是零)。 融資成本 牛熊證的發行價已包括融資成本。融資成本會隨牛熊證接近到期日而逐漸減少。牛熊證的年期愈長,總融資成本愈高。若一天牛熊證被收回,投資者即損失牛熊證整個有效期的融資成本。融資成本的計算程式載於牛熊證的上市文件。 衍生權證 時間損耗風險 假若其他情況不變,衍生權證愈接近到期日,價值會愈低,因此不能視為長線投資。波幅風險 衍生權證的價格可隨相關資產價格的引申波幅而升跌,投資者須注意相關資產的波幅。綜合複製策略的交易所買賣基金(合成 ETF) 市場風險 投資者會承受與合成 ETF 相關指數有關的政治、經濟、貨幣及其他風險。追踪誤差 合成 ETF 及相關指數的表現可能不一致。原因,舉例來說,可能是模擬策略失效、匯率、收費及支出等因素。交易對手風險 若合成 ETF 投資於衍生工具以追踪指數表現,投資者除了會承受與指數有關的風險外,亦會承受發行有關衍生工具的交易對手的信貸風險。此外,註冊機構亦應考慮有關衍生工具發行人的潛在連鎖影響及集中風險(例如由於衍生工具發行人主要是國際金融機構,因此若合成 ETF 的其中一個衍生工具交易對手倒閉,便可能對該合成 ETF 的其他衍生工具交易對手產生「連鎖」影響)。有些合成 ETF 備有抵押品以減低交易對手風險,但仍要面對當合成 ETF 的抵押品被變現時,抵押品的市值可能已大幅下跌的風險。 以折讓或溢價買賣 若合成 ETF 所追踪的指數/市場就投資者的參與設有限制,則為使合成 ETF 的價格與其資產淨值一致的增設或贖回單位機制的效能可能會受到影響,令合成 ETF 的價格相對其資產淨值出現溢價或折讓。投資者若以溢價買入合成 ETF,在基金終止時可能無法收回溢價。 債券風險 違責/信貸風險 發債機構未能如期支付利息或本金的風險。利率風險 利率上升時,定息債券的價格通常會下跌;若利率下跌則會推高定息債券的價格。如果你打算在到期日之前沽售債券,所得金額可能會低於買入價。此外,相對於年期較短的債券,年期較長的債券較易受利率變動所影響,即對利率的升跌較為敏感。舉例說,30 年期零息債券對利率調整的敏感度通常會較 10 年期的定息債券為高,這是因為零息債券只會在到期時才歸還本金,在此之前不會派付任何利息。零息債券的價值是把到期時須要歸還的本金,以貼現 (discounting)的方法來計算其現值。因此債券年期愈短,折讓率及利率變化對債券價值所帶來的影響亦愈少。 匯率風險 如果債券以外幣訂價,持有人將要面對匯率波動的風險。若債券持有人將收回的外幣本金及利息兌換為本地貨幣時適值外幣貶值,其收益將會減少。 流通量風險 需要現金周轉或打算將資金轉作其他投資的債券持有人,可能需要在債券到期前沽出債券,但如果債券在二手市場的流通量欠佳,則可能難以沽出債券套現。 再投資風險/贖回風險 若持有可贖回債券,當利率下調時,發債機構或會在到期前提早贖回債券。如果將債券收益再投資市場上其他債券,這些債券的孳息率一般都會較原先債券的為低。 股票風險 如果持有的是“可換股”或“可轉換”債券,投資者將要承受正股所帶來的股票風險,若正股價格下跌,債券價格亦通常會隨之下調。 通脹風險 投資債券的回報亦會因物價上漲而失去購買力。因此,以債券票息作為定期收入的投資者,必須考慮通脹所帶來的影響。 事件風險 每當發債機構進行合併或收購等企業活動,其信貸評級可能會下調。此外,若發債機構須發行大量新債以集資進行企業重組活動,該公司贖回現有債券的能力亦會減弱。 買賣外國證券的風險 你必須先了解外國證券買賣的性質以及將面臨的風險,然後方可進行外國證券的買賣。特別是,儘管本公司是聯交所的交易參與者,外國證券的買賣並不受聯交所所管轄,並且不會受到投資者賠償基金所保障。你應根據本身的投資經驗、風險承受能力以及其他相關條件,小心衡量自己是否適合參與該等買賣及徵求獨立專業意見。 在香港以外地方收取或持有的客戶資產的風險 持牌人或註冊人在香港以外地方收取或持有的客戶資產,是受到有關海外司法管轄區的適用法律及規例所監管的。這些法律及規例與《<證券及期貨條例>》(第 571 章)及根據該條例制訂的規則可能有所不同。因此,有關客戶資產將可能不會享有賦予在香港收取或持有的客戶資產的相同保障。 外幣交易風險 以外幣計算產品的買賣所帶來的利潤或招致的虧損(不論交易是否在你本身所在的司法管轄區或其他地區進行),均會在需要將產品的單位貨幣兌換成另一種貨幣時受到匯率波動的影響。 人民幣計價證券之風險 人民幣不能自由兌換。人民幣與外幣(包括港元)之間的轉換,是受中國的監管限制,並會影響以人民幣計價證券的流動性。人 民幣計價的證券可能沒有定期交易或活躍市場。因此,你或許不能及時出售,或大幅折讓其產品的價值以作出售。如人民幣貶值,以港元計價的投資亦會下降。 在香港聯合交易所有限公司買賣納斯達克-美國證券交易所證券的風險 按照納斯達克-美國證券交易所試驗計劃(“試驗計劃”)掛牌買賣的證券是為熟悉投資技巧的投資者而設的。你在買賣該項試驗計劃的證券之前,應先諮詢有關持牌人或註冊人的意見和熟悉該試驗計劃。你應知悉,按照該項試驗計劃掛牌買賣的證券並非以香港聯合交易所有限公司的主板或創業板作第一或第二上市的證券類別加以監管。 有關透過滬港通交易之重要文件及特別風險 以下是一些通過嘉信証券有限公司(” 公司”) 透過滬港通買賣上海證券交易所之風險及其他重要詳情。由於涉及風險,你只應在你完全理解滬港通之性質及你將承受之風險才進行有關交易。你應按你的經驗、目的、財務資源及其他因素小心考慮(及在有需要時資詢你的顧問)該等交易是否適合你。 你必須遵守中國內地及香港相關之法律與法規,和一切有關交易所之條例。在作出交易指示前,你必須接受並同意上述有關滬港通之...

Related to 強制收回風險

  • Waiver; Remedies Cumulative The rights and remedies of the parties to this Agreement are cumulative and not alternative. Neither any failure nor any delay by any party in exercising any right, power or privilege under this Agreement or any of the documents referred to in this Agreement will operate as a waiver of such right, power or privilege, and no single or partial exercise of any such right, power or privilege will preclude any other or further exercise of such right, power or privilege or the exercise of any other right, power or privilege. To the maximum extent permitted by applicable law, (a) no claim or right arising out of this Agreement or any of the documents referred to in this Agreement can be discharged by one party, in whole or in part, by a waiver or renunciation of the claim or right unless in writing signed by the other party; (b) no waiver that may be given by a party will be applicable except in the specific instance for which it is given; and (c) no notice to or demand on one party will be deemed to be a waiver of any obligation of that party or of the right of the party giving such notice or demand to take further action without notice or demand as provided in this Agreement or the documents referred to in this Agreement.

  • Remedies Cumulative In the event that the Company fails to observe or perform any covenant or agreement to be observed or performed under this Agreement, the Investor or any other holder of Registrable Securities may proceed to protect and enforce its rights by suit in equity or action at law, whether for specific performance of any term contained in this Agreement or for an injunction against the breach of any such term or in aid of the exercise of any power granted in this Agreement or to enforce any other legal or equitable right, or to take any one or more of such actions, without being required to post a bond. None of the rights, powers or remedies conferred under this Agreement shall be mutually exclusive, and each such right, power or remedy shall be cumulative and in addition to any other right, power or remedy, whether conferred by this Agreement or now or hereafter available at law, in equity, by statute or otherwise.

  • No Waiver; Remedies Cumulative No failure or delay on the part of any Agent or any Lender in the exercise of any power, right or privilege hereunder or under any other Credit Document shall impair such power, right or privilege or be construed to be a waiver of any default or acquiescence therein, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other power, right or privilege. The rights, powers and remedies given to each Agent and each Lender hereby are cumulative and shall be in addition to and independent of all rights, powers and remedies existing by virtue of any statute or rule of law or in any of the other Credit Documents. Any forbearance or failure to exercise, and any delay in exercising, any right, power or remedy hereunder shall not impair any such right, power or remedy or be construed to be a waiver thereof, nor shall it preclude the further exercise of any such right, power or remedy.

  • Warranties Cumulative The warranties set forth in this section are in addition to, and not in lieu of, any other warranties provided.

  • Rights and Remedies Cumulative Except as otherwise provided with respect to the replacement or payment of mutilated, destroyed, lost or stolen Securities in the last paragraph of Section 306, no right or remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right or remedy.

  • Other Remedies Except as otherwise provided herein, any and all remedies herein expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy.

  • Waiver and Cumulative Remedies No failure or delay by either party in exercising any right under this Agreement shall constitute a waiver of that right. Other than as expressly stated herein, the remedies provided herein are in addition to, and not exclusive of, any other remedies of a party at law or in equity.

  • Waiver; Remedies No failure on the part of Purchaser to exercise, and no delay in exercising, any right under this Guaranty shall operate as a waiver, nor shall any single or partial exercise of any right under this Guaranty preclude any other or further exercise of any other right. The remedies provided in this Guaranty are cumulative and not exclusive of any remedies provided by law or equity. In the event that Merchant fails to perform any obligation under the Agreement, Purchaser may enforce its rights under this Guaranty without first seeking to obtain performance for such default from Merchant or any other guarantor.

  • Rights Cumulative The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, that the Parties are entitled to under federal and state laws.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!